Association of Interleukin-10 Gene Polymorphisms with Ulcerative Colitis
https://doi.org/10.29413/ABS.2020-5.6.7
Abstract
This literature review is devoted to the study of the role of polymorphic variants of the anti-inflammatory interleukin-10 gene (Interleukin-10, IL10) in the etiology and pathogenesis of ulcerative colitis in patients of various ethnic groups.
Aim. To generalize the results obtained from electronic databases on the study of the characteristics of the course of ulcerative colitis in patients of different ethnic groups, taking into account the carriage of IL10 gene polymorphisms.
Materials and methods. Twenty-five studies were selected, including four meta-analyzes devoted to the study of associative relationships of single nucleotide polymorphisms (SNPs) of the IL10 gene isolated from blood samples at positions -592AA/CA, -819CT, -1082АА/GA, and rs3024505 in the development and course of ulcerative colitis.
Results. A number of researchers from Europe, Saudi Arabia report an increased incidence of ulcerative colitis among carriers of the IL10-1082AA SNP and a low incidence among carriers of -592AA. Positive associations of IL10-819CT with the prevalence of ulcerative colitis are presented in single reports from Europe, the Middle East and in a number of studies from Asian countries. However, the identified associations, even within the same population, are often contradictory. Perhaps the discrepancies are due to the ethnic heterogeneity of the groups in the considered cohorts, and therefore it is necessary to continue epidemiological studies with a large sample size in specific geographic areas.
About the Authors
I. V. Zhilin
Irkutsk Scientific Centre of Surgery and Traumatology
Russian Federation
Coloproctologist, Postgraduate, Irkutsk Scientific Centre of Surgery and Traumatology
Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation
Russian Federation
Coloproctologist, Postgraduate, Irkutsk Scientific Centre of Surgery and Traumatology
Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation
E. Yu. Chashkova
Irkutsk Scientific Centre of Surgery and Traumatology
Russian Federation
Cand. Sc. (Med.), Coloproctologist, Head of the Laboratory of Reconstructive Surgery of the Scientific Department of Clinical Surgery
Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation
Russian Federation
Cand. Sc. (Med.), Coloproctologist, Head of the Laboratory of Reconstructive Surgery of the Scientific Department of Clinical Surgery
Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation
A. A. Zhilina
Chita State Medical Academy
Russian Federation
Russian Federation
Cand. Sc. (Med.), Assistant Professor at the Department of Therapy of the Faculty of Advanced Training and Staff Retraining
Gorkogo str. 39A, Chita 672000, Russian Federation
A. V. Markovskiy
Chita State Medical Academy
Russian Federation
Junior Research Officer at the Laboratory of Molecular Genetics of Research Institute of Molecular Medicine
Gorkogo str. 39A, Chita 672000, Russian Federation
Russian Federation
Junior Research Officer at the Laboratory of Molecular Genetics of Research Institute of Molecular Medicine
Gorkogo str. 39A, Chita 672000, Russian Federation
A. D. Kim
Irkutsk Scientific Centre of Surgery and Traumatology
Russian Federation
Surgeon, Junior Research Officer at the Laboratory of Reconstructive Surgery of the Scientific Department of Clinical Surgery
Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation
Russian Federation
Surgeon, Junior Research Officer at the Laboratory of Reconstructive Surgery of the Scientific Department of Clinical Surgery
Bortsov Revolyutsii str. 1, Irkutsk 664003, Russian Federation
References
1. Tatiya-Aphiradee N, Chatuphonprasert W, Jarukamjorn K. Immune response and inflammatory pathway of ulcerative colitis. J Basic Clin Physiol Pharmacol. 2018; 30(1): 1-10. doi: 10.1515/jbcpp-2018-0036
2. Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019; 20: 6008. doi: 10.3390/ijms 20236008
3. Hernández-Rocha C, Ibáñez P, Molina ME, Klaassen J, Valenzuela A, Candia R, et al. Management of severe ulcerative colitis: An up-to-date. Rev Med Chil. 2017; 145(1): 75-84. doi: 10.4067/S0034-98872017000100013
4. Danese S. New therapies for inflammatory bowel disease: from the bench to the bedside. Gut. 2012; 61: 918-932.
5. Kim JW, Hwang SW, Park SH, Song TJ, Kim MH, Lee HS, et al. Clinical course of ulcerative colitis patients who develop acute pancreatitis. World J Gastroenterol. 2017; 23(19): 3505-3512. doi: 10.3748/wjg.v23.i19.3505
6. Serebrennikova SN, Seminskiy IZh, Semenov NV, Guzovskaya EV. Interleukin-1, interleukin-10 in the regulation of the inflammatory process. Sibirskiy meditsinskiy zhurnal (Irkutsk). 2012; 115(8): 5-7. (In Russ.).
7. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997; 24: 1-8. doi: 10.1111/j.1365-2370.1997.tb00001
8. Walter MR. The molecular basis of IL-10 function: from receptor structure to the onset of signaling. Curr Top Microbiol Immunol. 2014; 380: 191-212. doi: 10.1007/978-3-662-43492-5
9. Llopiz D, Ruiz M, Silva L, Sarobe P. Enhancement of antitumor vaccination by targeting dendritic cell-related IL-10. Front Immunol. 2018; 9: 1923. doi: 10.3389/fimmu.2018.01923
10. Diaz Orea MA, Muñoz Perez V, Gómez Conde E, Castellanos Sánchez VO, Gonzalez Lopez R, Flores Alonso JC, et al. Expression of cytokines interleukin-2, interleukin-4, interleukin-10 and transforming growth factor β in gastric adenocarcinoma biopsies obtained from Mexican patients. Asian Pac J Cancer Prev. 2017; 18(2): 577-582. doi: 10.22034/APJCP.2017.18.2.577
11. Tian S, Yan Y, Qi X, Li X, Li Z. Treatment of type II collageninduced rat rheumatoid arthritis model by interleukin 10 (IL10)- mesenchymal stem cells (BMSCs). Med Sci Monit. 2019; 25: 2923-2934. doi: 10.12659/MSM.911184
12. Georgescu SR, Tampa M, Caruntu C, Sarbu M, Mitran C, Mitran M, et al. Advances in understanding the immunological pathways in psoriasis. Int J Mol Sci. 2019; 20(3): E739. doi: 10.3390/ijms20030739
13. Sharma N, Toor D. Interleukin-10: Role in increasing susceptibility and pathogenesis of rheumatic fever/rheumatic heart disease. Cytokine. 2017; 90: 169-176. doi: 10.1016/j.cyto.2016.11.010
14. Dai W, Ye Z, Lu H, Su Q, Li H, Li L. Meta-analysis of the relationship between single nucleotide polymorphism of IL-10-1082G/A and rheumatic heart disease. Oncotarget. 2018; 9(15): 12343-12350. doi: 10.18632/oncotarget.23901
15. Mohammadi S, Saghaeian Jazi M, Zare Ebrahimabad M, Eghbalpour F, Abdolahi N, Tabarraei A, et al. Interleukin 10 gene promoter polymorphisms (rs1800896, rs1800871 and rs1800872) and haplotypes are associated with the activity of systemic lupus erythematosus and IL10 levels in an Iranian population. Int J Immunogenet. 2019; 46(1): 20-30. doi: 10.1111/iji.12407
16. Moore KW, de Waal Malefyt R, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19: 683-676.
17. Geginat J, Larghi P, Paroni M, Nizzoli G, Penatti A, Pagani M, et al. The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer. Cytokine Growth Factor Rev. 2016, 30: 87-93.
18. Huber S, Gagliani N, Esplugues E, O’Connor W, Huber FJ, Chaudhry A, et al. Th17 cells express interleukin-10 receptor and are controlled by Foxp3- and Foxp3+ regulatory CD4+ T-cells in an interleukin-10-dependent manner. Immunity. 2011; 34: 554-565.
19. Bateneva EI, Trofimov DYu, Khaitov RM, et al. Using quantitative polymerase chain reaction to assess the human cytokine profile. Immunology. 2006; 27(1): 9-13. (In Russ.).
20. Al-Robayan A, Arfin M, Saleh Al-Meghaiseeb E, Al-Amro R, Al-Asmari AK. Inflammatory bowel disease: The association of inflammatory cytokine gene polymorphisms. New Insights into Inflammatory Bowel Disease. 2016: 21. doi: 10.5772/65380
21. Engelhardt KR, Grimbacher B. IL-10 in humans: Lessons from the gut, IL-10/IL-10 receptor deficiencies, and IL-10 polymorphisms. Curr Top Microbiol Immunol. 2014; 380: 1-18. doi: 10.1007/978-3-662-43492-5
22. Zhu H, Lei X, Liu Q, Wanga Y. Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: A meta-analysis based on 17,585 subjects. Cytokine. 2013; 61(1): 146-153. doi: 10.1016/j.cyto.2012.09.009Get
23. Stashkevich DS, Vasilenko AG, Ivanova EL. Polymorphism of the IL-10 gene in patients with ulcerative colitis and irritable bowel syndrome in the Russian population of the Chelyabinsk region. Vestnik ChelGU. 2015; 21(376): 23-27. (In Russ.).
24. Stashkevich DS, Belayeva SV, Filippova YuYu, Burmistrova AL. Intergenic interactions of genes of cytokines IL1, IL1ra, IL6, IL10 and TNFа in patients with irritable bowel syndrome and ulcerative colitis in the Russian population of the Chelyabinsk region. Meditsinskaya immunologiya. 2018; 6: 921-926. (In Russ.).
25. Dorogeyev AE, Vdovichenko VI, Nagurna YaV, Haldi Hatem, Dprpfeyeva AА. Comparative prevalence and features of the course of ulcerative colitis in the countries of the same geographic meridian: Ukraine – Tunisia. Testing the North-South Hypothesis. Gastroenterologia. 2019; 53(1): 34-38. doi: 10.22141/2308-2097.53.1.2019.163455. (In Russ.).
26. Dorofeyev АE, Kharchenko NV, Rudenko NN, et al. The peculiarities of genetic profile in patients with inflammatory bowel disease in Ukraine and strategy for their management. Modern Gastroenterology. 2017; (93): 22-29.
27. Kiryan EA. Features of the influence of genetic factors on the development of intestinal pathology. Actual Problems of the Modern Medicine: Bulletin of Ukrainian Medical Stomatological Academy. 2017; 4-2(60): 169-172. (In Russ.).
28. Manish T, Pankaj K, Jitendra C, Arttrika R, Neha G, Vinod D, et al. Assessment of allelic and genotypic distribution of IL-6 and IL-10 cytokine genes in ulcerative colitis. Inflam Bowel Dis. 2014;20(suppl 1): S99-S100.
29. Mijac D, Petrovic IV, Djuranovic S, Perovic V, et al. The polymorphism rs3024505 (C/T) downstream of the IL10 gene is associated with Crohn’s disease in Serbian patients with inflammatory bowel disease. Tohoku J Exp Med. 2016; 240(1): 15-24.
30. Tedde A, Putignano LA, Bagnoli S, Congregati C, Milla M, Sorbi S, et al. Interleukin-10 promoter polymorphisms influence susceptibility to ulcerative colitis in a gender-specific manner. Scand J Gastroenterol. 2008; 43(6): 712-718.
31. Girardelli M, Basaldella F, Paolera SD, Vuch J, Tommasini A, Martelossi S, et al. Genetic profile of patients with early onset inflammatory bowel disease. Gene. 2018; 645: 18-29.
32. Magyari L, Kovesdi E, Sarlos P, Javorhazy A, Sumegi K, Melegh B. Interleukin and interleukin receptor gene polymorphisms in inflammatory bowel diseases susceptibility. World J Gastroenterol. 2014; 20(12): 3208-3222. doi: 10.3748/wjg.v20.i12.3208
33. Franke A, Balschun T, Karlsen TH, Sventoraityte J, Nikolaus S, Mayr G, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet. 2008; 40: 1319-1323. doi: 10.1038/ng.221
34. Doecke JD, Simms LA, Zhao ZZ, Huang N, Hanigan K, Krishnaprasad K, et al. Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 2013; 19: 240-245. doi: 10.1097/MIB.0b013e3182810041
35. Fernandez L, Martinez A, Mendoza JL, Urcelay E, et al. Interleukin-10 polymorphisms in Spanish patients with IBD. Inflamm Bowel Dis. 2005; 11(8): 739-743.
36. Castro-Santos P, Suarez A, López-Rivas L, Mozo L, et al. TNF alpha and IL-10 gene polymorphisms in inflammatory bowel disease. Association of -1082 AA low producer IL-10 genotype with steroid dependency. Am J Gastroenterol. 2006; 101(5): 1039-1047.
37. López-Hernández R, Valdés M, Campillo JA, MartínezGarcía P, et al. Pro- and anti-inflammatory cytokine gene singlenucleotide polymorphisms in inflammatory bowel disease. Int J Immunogenet. 2015; 42(1): 38-45.
38. Wu H, Guo JJ, He Y, Yin H, Shu JC. Relationship between IL-10 gene -819C/T polymorphism and the risk of inflammatory bowel disease: a meta-analysis. Afri Health Sci. 2016; 16(3): 866-872. doi: 10.4314/ahs.v16i3.30
39. Lv H, Jiang Y, Li J, Zhang M, Shang Z, Zheng J, et al. Association between polymorphisms in the promoter region of interleukin-10 and susceptibility to inflammatory bowel disease. Mol Biol Rep. 2014; 41(3): 1299-1310.
40. Kim TH, Kim BG, Shin HD, Kim JW. Tumor necrosis factoralpha and interleukin-10 gene polymorphisms in Korean patients with inflammatory bowel disease. Kor J Gastroenterol. 2003; 42(5); 377-386.
41. Celik Y, Dagli U, Kiliç MY, Törüner M. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease. Scand J Gastroenterol. 2006; 41(5): 559-565.
42. Gok I, Uçar F, Ozgur O, Efe H. Analysis Of cytokine gene polymorphism allelic variation in the Turkish population with inflammatory bowel disease. Biomed Res. 2014; 25(4): 26-34.
43. Al-Meghaiseeb ES, Al-Robayan AA, Al-Otaibi MM, Arfin M, Al-Asmari AK. Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease. J Inflamm Res. 2016; 9: 133-140. doi: 10.2147/JIR.S101225
44. Daryani EN, Saghazadeh A, Moossavi S, Sadr M, Shahkarami S, Soltani S, et al. Interleukin-4 and interleukin-10 gene polymorphisms in patients with inflammatory bowel disease. Immunol Invest. 2017; 46(7): 714-729. doi: 10.1080/08820139.2017.1360343
Review
For citations:
Zhilin I.V., Chashkova E.Yu., Zhilina A.A., Markovskiy A.V., Kim A.D. Association of Interleukin-10 Gene Polymorphisms with Ulcerative Colitis. Acta Biomedica Scientifica. 2020;5(6):58-65. (In Russ.) https://doi.org/10.29413/ABS.2020-5.6.7
Views:
798
.png)
Email this article 
